These multidimensional, YKL-40-associated changes in the leukocyte profiles of patients with advanced COPD may be useful for personalized treatment and a better understanding of AECOPD immunopathology. The gene discussed is CHI3L1; the disease is chronic obstructive pulmonary disease.